Free Trial
NYSEARCA:BBHCRRD

VanEck Vectors Biotech ETF (BBHCRRD) Price, Holdings, & News

About VanEck Vectors Biotech ETF (NYSEARCA:BBHCRRD)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
Assets Under Management
$348.34 million
Dividend Yield
N/A
Net Expense Ratio
0.00%
Aggregate Rating
N/A

ETF Overview

VanEck Vectors Biotech ETF Expenses

TypeBBHCRRDNYSEARCA ETFsAll ETFs
Management Fee0.00%0.51%0.52%
Other Expenses0.00%0.58%0.54%
Total Expense0.00%0.73%0.71%
Fee Waiver0.00%-0.68%-0.58%
Net Expense0.00%0.58%0.59%
Receive BBHCRRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Vectors Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

BBHCRRD ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com

BBHCRRD ETF - Frequently Asked Questions

Shares of BBHCRRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Fund Details

Issuer
Fund Name
VanEck Vectors Biotech ETF
Tax Classification
Current Symbol
NYSEARCA:BBHCRRD
Inception Date
1/1/2100
Fund Manager
N/A
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Benchmark
N/A
Category
Focus
Development Level
Region
Number of Holdings
0

Fund Statistics

Assets Under Management
$348.34 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NYSEARCA:BBHCRRD) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners